Patent ID: 7846950

Claim:
A compound structurally represented by Formula I wherein; R1 is independently wherein the bond directed to the zig-zag lines indicates the point of attachment to the position indicated by R1 in Formula I; R2 is independently at each occurrence —H, -halogen, —(C 1 -C 3 ) alkyl (optionally substituted with one to three halogens), —CN, —C(O)R7, —C(O)OR7, —CO(O)Li, —C(O)(C 3 -C 5 )cycloalkyl, C(O)NR7R8, —OCF 3 , —OR7, —NO 2 , —NR7R8, —NR9SO 2 R7, —NR9C(O)R7, —NR9CO 2 R7, —NR9C(O)NR7R8, —SR7, —SO 2 R7, —SO 2 CF 3 , —SO 2 NR7R8, or —S(O)R7; R3 is independently at each occurrence —H, —(C 1 -C 3 ) alkyl (optionally substituted with one to three halogens), —SO 2 R7, —C(O)R7, —C(O)NR7R8, or —C(O)OR7; R4 and R5 are independently —H, —OH, -halogen, —(C 1 -C 3 ) alkyl (optionally substituted with one to three halogens), or —OR9; R6 is independently at each occurrence —H, -halogen, —(C 1 -C 3 ) alkyl (optionally substituted with one to three halogens), —NH 2 , —NR7R8, —OH, or —OR7; R7 and R8 are independently at each occurrence —H, or —(C 1 -C 2 ) alkyl (optionally substituted with one to three halogens), wherein R7 and R8 can combine with the atom to which they are attached to form a four to six membered ring; and R9 is independently at each occurrence —H or —(C 1 -C 3 ) alkyl (optionally substituted with one to three halogens); or a stereoisomer thereof; or a pharmaceutically acceptable salt thereof.